Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Subscribe To Our Newsletter & Stay Updated
